130 related articles for article (PubMed ID: 21527361)
1. Autoimmune bullous diseases the spectrum of infectious agent antibodies and review of the literature.
Sagi L; Baum S; Agmon-Levin N; Sherer Y; Katz BS; Barzilai O; Ram M; Bizzaro N; SanMarco M; Trau H; Shoenfeld Y
Autoimmun Rev; 2011 Jul; 10(9):527-35. PubMed ID: 21527361
[TBL] [Abstract][Full Text] [Related]
2. Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200.
Lidar M; Lipschitz N; Langevitz P; Barzilai O; Ram M; Porat-Katz BS; Pagnoux C; Guilpain P; Sinico RA; Radice A; Bizzaro N; Damoiseaux J; Tervaert JW; Martin J; Guillevin L; Bombardieri S; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():649-57. PubMed ID: 19758211
[TBL] [Abstract][Full Text] [Related]
3. Novel antiphospholipid antibodies in autoimmune bullous diseases.
Sagi L; Baum S; Barzilai O; Ram M; Bizzaro N; SanMarco M; Shoenfeld Y; Sherer Y
Hum Antibodies; 2014; 23(1-2):27-30. PubMed ID: 25812700
[TBL] [Abstract][Full Text] [Related]
4. The role of infections in the immunopathogensis of systemic sclerosis--evidence from serological studies.
Arnson Y; Amital H; Guiducci S; Matucci-Cerinic M; Valentini G; Barzilai O; Maya R; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():627-32. PubMed ID: 19758208
[TBL] [Abstract][Full Text] [Related]
5. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
[TBL] [Abstract][Full Text] [Related]
6. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role.
Lidar M; Langevitz P; Barzilai O; Ram M; Porat-Katz BS; Bizzaro N; Tonutti E; Maieron R; Chowers Y; Bar-Meir S; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():640-8. PubMed ID: 19758210
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
[TBL] [Abstract][Full Text] [Related]
8. Increased serum levels of a proliferation-inducing ligand in patients with bullous pemphigoid.
Watanabe R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Kuwano Y; Tada Y; Maruyama N; Okochi H; Tamaki K
J Dermatol Sci; 2007 Apr; 46(1):53-60. PubMed ID: 17250993
[TBL] [Abstract][Full Text] [Related]
9. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
10. Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden.
Shapira Y; Agmon-Levin N; Renaudineau Y; Porat-Katz BS; Barzilai O; Ram M; Youinou P; Shoenfeld Y
Exp Mol Pathol; 2012 Dec; 93(3):386-90. PubMed ID: 23022373
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
12. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
13. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
[TBL] [Abstract][Full Text] [Related]
14. Identification of different circulating autoantibodies in patients with bullous pemphigoid and pemphigus vulgaris by means of immunoblotting.
Kiss M; Husz S; Molnár K; Dobozy A
Acta Microbiol Immunol Hung; 1996; 43(2-3):115-23. PubMed ID: 8876727
[TBL] [Abstract][Full Text] [Related]
15. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
16. A case of bullous pemphigoid with antibodies against intercellular 130 kd antigen.
Takahashi H; Wada T; Matsuo S; Iwatsuki K; Iizuka H
J Dermatol; 1995 Aug; 22(8):576-81. PubMed ID: 7560455
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in patients with autoimmune blistering disease.
Echigo T; Hasegawa M; Inaoki M; Yamazaki M; Sato S; Takehara K
J Am Acad Dermatol; 2007 Sep; 57(3):397-400. PubMed ID: 17637483
[TBL] [Abstract][Full Text] [Related]
18. Frequency of seropositivity against infectious agents amongst pemphigus vulgaris patients: a case-control study on Strongyloides stercoralis, Helicobacter pylori, Toxoplasma gondii, Leishmania major, and Epstein-Barr virus.
Mortazavi H; Hejazi P; Khamesipour A; Mohebali M; Ehsani AH; Mohammadi Y; Farahani IV; Amirzargar AA
Int J Dermatol; 2015 Nov; 54(11):e458-65. PubMed ID: 26175264
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of circulating CD40 ligand in patients with bullous pemphigoid: preliminary results.
Watanabe R; Ishiura N; Nakashima H; Yazawa N; Kuwano Y; Tada Y; Okochi H; Fujimoto M; Tamaki K
Dermatology; 2007; 215(3):180-6. PubMed ID: 17823512
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid and pemphigus vulgaris: correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels.
Ameglio F; D'Auria L; Cordiali-Fei P; Mussi A; Valenzano L; D'Agosto G; Ferraro C; Bonifati C; Giacalone B
J Biol Regul Homeost Agents; 1997; 11(4):148-53. PubMed ID: 9582615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
